Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: MOLECULAR EXPRESS, INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2022-07-01 to 2023-08-31
Current total value of award: $300000
Description: VESIVAX HIVGP41E VACCINE DESIGN